Stock Price & Analysis

The S1 support level for FHTX Stock is $5.07 ,The R1 resistant level for FHTX Stock is $6.39.

As of the end of day on 2025-02-26, the price of FHTX Stock was $5.02.

The target price for FHTX Stock according to analyst rating is 11.80, with the highest price target at 18.00 and the lowest at 4.00. Analysts have a Strong Buy rating on FHTX Stock overall.

The market cap of FHTX is $283.5M.

Foghorn Therapeutics Inc. is a clinical-stage biotechnology company engaged in developing medicines that modulate gene expression through selectively targeting the chromatin regulatory system for therapeutic intervention in oncology. Its Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing to identify, validate and potentially drug targets within the system. The Company’s Traffic Control platform discovers and develops drugs in oncology and other therapeutic areas, including virology, autoimmune disease and neurology. The Company is developing FHD-286, a selective, allosteric ATPase inhibitor and which is evaluating two separate Phase I studies in metastatic uveal melanoma and relapsed and/or refractory acute myeloid leukemia, and myelodysplastic syndrome. It is also developing FHD-609, a targeted protein degrader, and which is evaluating in a Phase I study in synovial sarcoma.

FHTX has a total of 116 employees.